Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Change in Inventory (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Change in Inventory for 4 consecutive years, with -$27735.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory fell 206.61% to -$27735.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $319650.0, a 291.78% increase, with the full-year FY2024 number at -$23405.0, up 89.0% from a year prior.
  • Change in Inventory was -$27735.0 for Q3 2025 at 60 Degrees Pharmaceuticals, down from $26183.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $330474.0 in Q1 2025 to a low of -$152542.0 in Q4 2023.
  • A 4-year average of $1973.7 and a median of -$20571.0 in 2022 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: tumbled 227.76% in 2023, then soared 1173.25% in 2025.
  • 60 Degrees Pharmaceuticals' Change in Inventory stood at -$46541.0 in 2022, then crashed by 227.76% to -$152542.0 in 2023, then skyrocketed by 93.92% to -$9272.0 in 2024, then plummeted by 199.13% to -$27735.0 in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Change in Inventory are -$27735.0 (Q3 2025), $26183.0 (Q2 2025), and $330474.0 (Q1 2025).